Search results
Results from the WOW.Com Content Network
[1] Antimicrobial resistance (AMR or AR) occurs when microbes evolve mechanisms that protect them from antimicrobials, which are drugs used to treat infections. [2] This resistance affects all classes of microbes, including bacteria (antibiotic resistance), viruses (antiviral resistance), protozoa (antiprotozoal resistance), and fungi ...
reduce/eliminate any unnecessary applications of antimicrobials, i.e. to stem antimicrobial overuse, e.g. giving antibacterial drugs for viral infections, and thus antimicrobial resistance, ensure that human and animal patients who need antimicrobials receive the optimal drug for them, at the correct time, at an effective dose, via the correct ...
Antibiotic inactivation: bacteria create proteins that can prevent damage caused by antibiotics, they can do this in two ways. First, inactivating or modifying the antibiotic so that it can no longer interact with its target. Second, degrading the antibiotic directly. [7] Multidrug efflux pumps: The use of transporter proteins to expel the ...
In addition to developing new antibacterial treatments, it is important to reduce the selection pressure for the emergence and spread of antimicrobial resistance (AMR), such as antibiotic resistance. Strategies to accomplish this include well-established infection control measures such as infrastructure improvement (e.g. less crowded housing ...
The One Health Trust's ResistanceMap is a collection of tools summarizing national and subnational data on antimicrobial use and resistance globally. [30] Since its launch in 2010, ResistanceMap has been used to inform researchers, policy makers, and the public of important trends in drug resistance and antibiotic use. [31] [32]
Antivirulence is the concept of blocking virulence factors. [1] In regards to bacteria, the idea is to design agents that block virulence rather than kill bacteria en masse, as the current regime results in much more selective pressure (on antibiotic resistance).
Drug resistance is the reduction in effectiveness of a medication such as an antimicrobial or an antineoplastic in treating a disease or condition. [1] The term is used in the context of resistance that pathogens or cancers have "acquired", that is, resistance has evolved.
In clinical medicine, antibiotics are most frequently prescribed on the basis of a person's symptoms and medical guidelines.This method of antibiotic selection is called empiric therapy, [1] and it is based on knowledge about what bacteria cause an infection, and to what antibiotics bacteria may be sensitive or resistant. [1]